Concepedia

Monika McClellan

MM

8

Publications

906

Citations

8

H-Index

1996

Active since

Affiliations

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology(Current)

Robert Bosch Hospital

Klinik Schillerhöhe

Monika McClellan is an author at Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology specializing in lung cancer, cancer research, and medicine.

Top concepts

Publications per year

1996–2006

8

Publications

8

Prevalence of CD44+/CD24−/low Cells in Breast Cancer May Not Be Associated with Clinical Outcome but May Favor Distant Metastasis

Benny K. Abraham, Péter Fritz, Monika McClellan et al. · Clinical Cancer Research · 2005 · 533 citations · Full text

Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment

Heiko van der Kuip, Thomas E. Mürdter, Maike Sonnenberg et al. · BMC Cancer · 2006 · 110 citations · Full text

Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site.

Thomas E. Mürdter, Bernhard Sperker, K T Kivistö et al. · PubMed · 1997 · 73 citations

, , +15

Dose Optimization of a Doxorubicin Prodrug (HMR 1826) in Isolated Perfused Human Lungs: Low Tumor pH Promotes Prodrug Activation by β-Glucuronidase

Thomas E. Mürdter, Godehard Friedel, Janne T. Backman et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 57 citations

Combined cytotoxic action of Viscum album agglutinin-1 and anticancer agents against human A549 lung cancer cells.

Isabel Siegle, Péter Fritz, Monika McClellan et al. · PubMed · 2001 · 49 citations

Rows per page

1–5 of 8